Steven Basta is President and Chief Executive Officer of Phathom Pharmaceuticals, Inc. (PHAT). The company reported total compensation of $6,968,070 for fiscal year 2025.
| Salary | $525,000 |
|---|---|
| Bonus | $0 |
| Stock awards | $1,986,600 |
| Option awards | $3,983,144 |
| Non-equity incentive plan | $455,701 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $17,625 |
| Total | $6,968,070 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Phathom Pharmaceuticals, Inc. filed April 7, 2026, accession 0001193125-26-144570.
| Peer-group chief executive median | $7,509,618 |
|---|---|
| Difference from that median | $-541,548 |
| Percentile within the disclosed peer group | 44th |
| Peers with a disclosed figure | 15 |
Medians and percentiles are computed across the peer group Phathom Pharmaceuticals, Inc. discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Steven Basta this page | President and Chief Executive Officer | $6,968,070 |
| Terrie Curran | Former President and Chief Executive Officer | $4,936,791 |
| Sanjeev Narula | Chief Financial and Business Officer | $3,617,962 |
| Azmi Nabulsi | Former Chief Operating Officer | $2,714,314 |
| Anne Marie Cook | Chief Legal Officer and Secretary | $2,100,002 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Phathom Pharmaceuticals, Inc. compensation brief.
Steven Basta's compensation sits inside Phathom Pharmaceuticals, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.